NewcelX Ltd. (NCEL) stock
NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.54−0.15 (-5.58%)
Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –
NewcelX enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
NewcelX's enterprise value was $14.36M on Nov 11, 2026, against $16.35M a year earlier. Over the last 5 years it ranged from $7.59M to $490.94M, with a median of $72.21M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $14.36M | +89.3% |
| 2025 | Dec 31, 2025 | $7.59M | -62.5% |
| 2024 | Dec 31, 2024 | $20.25M | -90.3% |
| 2023 | Dec 29, 2023 | $208.78M | -8.5% |
| 2022 | Dec 30, 2022 | $228.08M | +79.8% |
| 2021 | Dec 31, 2021 | $126.87M | – |
See a number that looks wrong?